BETAGAN (Allergan, Inc.)


Welcome to the PulseAid listing for the BETAGAN drug offered from Allergan, Inc.. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Allergan, Inc.
NON-PROPRIETARY NAME: levobunolol hydrochloride
SUBSTANCE NAME: LEVOBUNOLOL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1986-07-24
END MARKETING DATE: 0000-00-00


BETAGAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBETAGAN from Allergan, Inc.
LABELER NAME: Allergan, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/mL)
START MARKETING DATE: 1986-07-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0023-4385_15540135-9b4e-4539-911d-ec0a00379143
PRODUCT NDC: 0023-4385
APPLICATION NUMBER: NDA019219

Other LEVOBUNOLOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.BETAGAN
Bausch & Lomb IncorporatedLevobunolol Hydrochloride
Pacific Pharma, Inc.LEVOBUNOLOL HYDROCHLORIDE
Physicians Total Care, Inc.Levobunolol Hydrochloride
Sandoz IncLevobunolol Hydrochloride